Pharma-Bio Serv (OTCMKTS:PBSV) Releases Earnings Results, Beats Expectations By $0.35 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) released its earnings results on Monday. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.35, reports. The business had revenue of $2.47 million during the quarter, compared to analysts’ expectations of $2.70 million. Pharma-Bio Serv had a negative net margin of 8.18% and a negative return on equity of 5.61%.

Pharma-Bio Serv Stock Down 21.8 %

PBSV stock opened at $0.43 on Wednesday. The stock has a market capitalization of $9.86 million, a P/E ratio of -14.33 and a beta of 0.53. Pharma-Bio Serv has a 52 week low of $0.31 and a 52 week high of $0.90. The firm has a 50-day simple moving average of $0.55 and a 200-day simple moving average of $0.57.

Pharma-Bio Serv Dividend Announcement

The business also recently announced a dividend, which will be paid on Thursday, March 20th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.075 per share. The ex-dividend date is Friday, February 28th. Pharma-Bio Serv’s dividend payout ratio is currently -250.00%.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.